Johnson & Johnson

NYS : JNJ
Pharmaceuticals
New Brunswick NJ
2013 Revenue (US$ Millions)$71,312
2012 Revenue (US$ Millions)$67,224
Revenue Growth (%)6.08%
Net Income (US$ Millions)$13,831
Common Shares Outstanding (Millions)$2,821
Earnings Per Share (US$)$4.81
Price To Earnings Ratio95.63
Total Equity (US$ Millions)$74,053
Profit Margin (%)19.40%
Return On Equity (%)21.34%
Long Term Debt (US$ Millions)$13,328
Debt To Equity Ratio (%)0.18%
Market Capitalization (US$ Millions)$260,485
Total Assets (US$ Millions)$132,683
Return on Assets (%)11.4
Current Assets (US$ Millions)$56,407
Inventories (US$ Millions)$7,878
Current Liabilities (US$ Millions)$25,675
Cost of Goods Sold (US$ Millions)$22,342
Asset Turnover0.54
Inventory Turnover2.91
ExchangeNYS